2016
DOI: 10.1248/cpb.c16-00382
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Structural Revision of Cyslabdan

Abstract: Cyslabdan was isolated from the culture broth of Streptomyces sp. K04-0144 as a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus. We accomplished the synthesis of cyslabdan according to a previously reported structure. However, we subsequently found that this structure was incorrect; our analysis of natural cyslabdan showed that it possessed R stereochemistry at the C8 position, not S, as had previously been reported. Thus, we completed the protecting-group-free synthesi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
6
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 32 publications
3
6
0
Order By: Relevance
“…Cyslabdan is a diterpene natural product bearing a N -acetylcysteine residue isolated from Streptomyces cyslabdanicus K04-0144. While cyslabdan alone does not display significant antibacterial activity, it potentiates the activity of carbapenem antibiotics against methicillin-resistant Staphylococcus aureus by >1000-fold. Genome mining for the biosynthetic gene cluster identified four genes cld A–D, which when expressed in a heterologous host lead to the production of cyslabdan A . Additionally, a new compound bearing an epoxide was detected.…”
Section: Nonenzymatic C–s Bond Formationsmentioning
confidence: 99%
“…Cyslabdan is a diterpene natural product bearing a N -acetylcysteine residue isolated from Streptomyces cyslabdanicus K04-0144. While cyslabdan alone does not display significant antibacterial activity, it potentiates the activity of carbapenem antibiotics against methicillin-resistant Staphylococcus aureus by >1000-fold. Genome mining for the biosynthetic gene cluster identified four genes cld A–D, which when expressed in a heterologous host lead to the production of cyslabdan A . Additionally, a new compound bearing an epoxide was detected.…”
Section: Nonenzymatic C–s Bond Formationsmentioning
confidence: 99%
“…His main research interests are the combinatorial biosynthesis of new bioactive natural products from microorganisms and construction of chassis to improve the yield of these compounds using synthetic biology tools. stereochemistry that was previously reported by Ōmura et al [25] Two congeners, cyslabdans B (3) and C (4), were later obtained from the same strain, Streptomyces sp. K04-0144, [9b] which was later named S. cyslabdanicus K04-0144.…”
Section: Labdane-type Diterpenoidsmentioning
confidence: 67%
“…K04‐0144 [9a,24] (Figure 3). By the total synthesis of 2 , Nagamitsu and colleagues revised the stereochemistry at C8 position to be R , rather than the S stereochemistry that was previously reported by Ōmura et al [25] . Two congeners, cyslabdans B ( 3 ) and C ( 4 ), were later obtained from the same strain, Streptomyces sp.…”
Section: Structures Of Diterpenoids From Streptomycesmentioning
confidence: 99%
See 1 more Smart Citation
“…Remarkably, this interpretation has not received subsequent verification, possibly as a result of the separation between laboratories having access to the marine-derived structure, and laboratories with the ability to carry out a rigorous mechanistic study using enzymes from notable bacterial pathogens. Synthetic access to cyslabdan structures is, however, established [ 94 ]. Lipoxazolidinones are a class of marine-derived Gram-positive antibiotics [ 95 , 96 ].…”
Section: Do Marine Organisms Biosynthesize Exceptional Inhibitors Of ...mentioning
confidence: 99%